Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05890053
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-06
First Post:
2023-02-26
Brief Title:
To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia
Sponsor:
Haisco Pharmaceutical Group Co Ltd
Organization:
Haisco Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A 52-week Open Phase III Study Evaluating the Long-term Safety and Efficacy of HSK16149 Capsules in Chinese Patients With Peripheral Neuralgia
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigate the long-term52 weeks safety and efficacy of HSK16149 capsules in Chinese patients with periphcral neuralgia
Detailed Description:
Investigate the long-term52 weeks safety and efficacy of HSK16149 capsules in Chinese patients with Peripheral neuropathic pain
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None